NOVEL TESTS FOR THERAPEUTIC DRUG MONITORING NOW AVAILABLE IN THE CLINICAL CHEMISTRY LABORATORY
Effective 1/29/2015, VORICONAZOLE (Anti-Fungal) AND EVEROLIMUS (Immunosuppressant) testing will be available using Quantitative Tandem Liquid Mass spectrometry in the Clinical Chemistry Laboratory. p>
VORICONAZOLE (Trough): Indications for Ordering: Therapeutic monitoring for individuals taking an antifungal drug (trough collection)
•Voriconazole is used in the treatment of
• Due to toxicity risk and need for optimal efficacy in patient therapy, all antifungal treatment should be monitored with trough levels
Indications for Ordering: Therapeutic monitoring for individuals taking everolimus
• Everolimus is used for prophylaxis of organ rejection in patients receiving a kidney and liver transplant.
• Everolimus is used in treatment of renal cell carcinoma
• Trough concentrations should be assessed ~2 weeks after beginning treatment
Testing will initially be offered on weekdays with a 24 hour TAT. All test requirements, therapeutic and toxic ranges are on the Pathology Online Catalog.
Please feel free to contact Dr. Devaraj at 832-826-1717 if you have any questions.